FGF18 alleviates sepsis-induced acute lung injury by inhibiting the NF-κB pathway.

Authors:
Hu Z; Dai J; Xu T; Chen H; Shen G and 4 more

Journal:
Respir Res

Publication Year: 2024

DOI:
10.1186/s12931-024-02733-1

PMCID:
PMC10902988

PMID:
38419044

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Respir Res

Abbreviation: Respir Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A combination of mild-moderate hypoxemia and low compliance is highly prevalent in persistent ARDS:…
Papoutsi E; Andrianopoulos I; Mavrikaki V and 8 more (2024) - Transparency Score: 3/6
Advancing accuracy in breath testing for lung cancer: strategies for improving diagnostic precision…
Chen KC; Kuo SW; Shie RH and 1 more (2024) - Transparency Score: 3/6
Associations between long-term ozone exposure and small airways function in Chinese young adults: a…
Feng S; Yang L; Dou S and 10 more (2024) - Transparency Score: 3/6
Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomiz…
Eltahan NH; Elsawy NH; Abdelaaty KM and 3 more (2024) - Transparency Score: 4/6
Bhlhe40 deficiency attenuates LPS-induced acute lung injury through preventing macrophage pyroptosi…
Hu X; Zou M; Zheng W and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe animal experiment protocol was reviewed and approved by the Wenzhou Medical University Institutional Animal Care and Use Committee. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Nature Science Foundation of China (82273560) and the Zhejiang Provincial Natural Science Foundation (LY22H110002)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025